UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Expert review of anti-infective therapy, ISSN 1478-7210, 12/2013, Volume 11, Issue 12, pp. 1269 - 1279
nucleotide analogue | direct-acting antiviral | chronic hepatitis C | Nucleotide analogue | Direct-acting antiviral | Chronic hepatitis C | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hepacivirus - drug effects | Recombinant Proteins - therapeutic use | Antiviral Agents - therapeutic use | Humans | Ribavirin - therapeutic use | Biomarkers, Pharmacological | Interferon-alpha - therapeutic use | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Genotype | Treatment Outcome | Clinical Trials as Topic | Hepatitis C, Chronic - drug therapy | Polyethylene Glycols - therapeutic use | Drug Synergism | Uridine Monophosphate - analogs & derivatives | Hepacivirus - growth & development | Drug Therapy, Combination | Sofosbuvir | Uridine Monophosphate - therapeutic use | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 18, pp. 1685 - 1694
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Viral hepatitis | Infectious diseases | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Hepacivirus - isolation & purification | Oligonucleotides - therapeutic use | Antiviral Agents - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Genotype | Male | MicroRNAs - metabolism | Oligonucleotides - adverse effects | RNA, Viral - blood | Binding Sites - genetics | Hepatitis C, Chronic - drug therapy | Dose-Response Relationship, Drug | Antiviral Agents - adverse effects | Injections, Subcutaneous | Adult | Female | Aged | Mutation | Hepatitis C, Chronic - genetics | MicroRNAs - chemistry | Antiviral agents | Care and treatment | MicroRNA | Research | Hepatitis C virus | Drug therapy | Health aspects | Liver diseases | Mortality | Liver | Body weight | Chronic infection | Antisense oligonucleotides | Genomes | Nucleic acids | Gene expression | Drug resistance | Patients | Hepatitis | miRNA | Phosphorothioate | Antisense DNA | Hepatitis C | Liver cirrhosis | Genotypes | Viral infections | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 384, Issue 9956, pp. 1756 - 1765
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recombinant Proteins - therapeutic use | Uridine Monophosphate - administration & dosage | Simeprevir | Confidence Intervals | Follow-Up Studies | Humans | Middle Aged | Hepacivirus - genetics | Male | Reference Values | Polyethylene Glycols - therapeutic use | Dose-Response Relationship, Drug | Adult | Female | Drug Therapy, Combination | Liver Function Tests | Severity of Illness Index | Drug Administration Schedule | Risk Assessment | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Sulfonamides - therapeutic use | Heterocyclic Compounds, 3-Ring - therapeutic use | Uridine Monophosphate - analogs & derivatives | Hepatitis C, Chronic - genetics | Sofosbuvir | Hepatitis | Genotype & phenotype | Liver diseases | Biopsy | Infections | Drug therapy | Liver cirrhosis | Index Medicus | Abridged Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 12/2011, Volume 54, Issue 6, pp. 1956 - 1965
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Hepacivirus - drug effects | Antiviral Agents - pharmacokinetics | Double-Blind Method | Humans | Middle Aged | Half-Life | Imidazoles - administration & dosage | Male | RNA, Viral - blood | Imidazoles - pharmacokinetics | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Viral Load | Adolescent | Adult | Female | Viral Nonstructural Proteins - antagonists & inhibitors | Hepatitis | Genotype & phenotype | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Current opinion in infectious diseases, ISSN 0951-7375, 02/2013, Volume 26, Issue 1, pp. 50 - 57
direct-acting antiviral | drug-to-drug interactions | HIV/hepatitis C virus coinfection | chronic hepatitis C | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Hepacivirus - drug effects | Antiviral Agents - pharmacokinetics | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Protease Inhibitors - pharmacokinetics | Humans | Clinical Trials as Topic | Hepatitis C, Chronic - drug therapy | Coinfection - virology | Drug Interactions | Anti-HIV Agents - pharmacokinetics | HIV Infections - complications | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 401 - 408
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Viral hepatitis | Infectious diseases | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Immunomodulators | Other diseases. Semiology | Recombinant Proteins - therapeutic use | Uridine Monophosphate - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Male | Secondary Prevention | Polyethylene Glycols - therapeutic use | Young Adult | Time Factors | Ribavirin - administration & dosage | Adult | Female | Headache - chemically induced | Uridine Monophosphate - therapeutic use | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Adolescent | Liver Cirrhosis - pathology | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Protease inhibitors | Proteases | Gastrointestinal diseases | Clinical trials | Product development | Genetic aspects | Interferon | Hepatitis C | Health aspects | Liver cirrhosis | Viral antigens | Index Medicus
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 11/2017, Volume 66, Issue 11, pp. 2903 - 2914
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Cell Line | RNA Splice Sites - genetics | Diabetes Mellitus, Type 2 - genetics | Humans | Liver | Gene Expression Regulation - physiology | European Continental Ancestry Group | Genotype | Insulin-Like Growth Factor II - metabolism | Genetic Variation | Stem Cells | Mexican Americans - genetics | Insulin-Like Growth Factor II - genetics | Protein Isoforms | Mexico | Adipose Tissue | Health care | Reproductive health | Medical research | Adipose tissue | Splicing | Exons | Diabetes mellitus | Genomes | Genetic diversity | Population genetics | Genetic variance | Gene frequency | Alleles | Hemoglobin | Diabetes | Insulin-like growth factor II | Index Medicus | Abridged Index Medicus | Metabolomics | Genetics | 0409 | Proteomics
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2008, Volume 6, Issue 5, pp. 484 - 490
Gastroenterology and Hepatology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Function Tests | Severity of Illness Index | United States - epidemiology | Risk Assessment | Antiviral Agents - therapeutic use | Humans | Interferon-alpha - therapeutic use | Hispanic Americans - statistics & numerical data | Male | Hepatitis C, Chronic - ethnology | Recombinant Proteins | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Incidence | Drug Resistance, Viral - ethnology | Survival Analysis | Female | Development and progression | Insulin resistance | Hepatitis C | Biological response modifiers | Hispanic Americans | Index Medicus
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 12/2012, Volume 61, Issue 12, pp. 3314 - 3321
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | RNA-Binding Proteins - genetics | Calcium-Calmodulin-Dependent Protein Kinase Type 1 - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | KCNQ1 Potassium Channel - genetics | Transcription Factor 7-Like 2 Protein - genetics | Zinc Transporter 8 | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Genotype | Male | Transcription Factors - genetics | Homeodomain Proteins - genetics | Cyclin-Dependent Kinase 5 - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | tRNA Methyltransferases | Polymorphism, Single Nucleotide - genetics | Cation Transport Proteins - genetics | Female | Mexico | Type 2 diabetes | Racially mixed people | Genetic variation | Mexicans | Genetic aspects | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus | Metabolomics | Genetics | Genomes | Proteomics
Journal Article